Product Information

EPRONTIA 25 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $2.5545 per ML under NDC 52652900102. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Nov 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EPRONTIA 25 MG/ML SOLUTION

Topiramate
$2.5545per ML

Strength

25 mg/mL

NDC

52652900102

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Effective Date

1/1/2026

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA214679

FDA Approved

11/5/2021

TE Code

AB

On Market Since

12/6/2021

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for EPRONTIA 25 MG/ML SOLUTION has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 11.4%. The table below summarizes its recorded NADAC range and movement.

Current price$2.5545 per ML
All-time high$2.5545 (Aug 19, 2026)
All-time low$2.2854 (Nov 20, 2024)
52-week high$2.5545
52-week low$2.4771
Median price$2.4801
Average price$2.4424
Largest weekly change+9.0% (Jan 15, 2025)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+3.1%

3Y

N/A

5Y

N/A

All

+11.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 38%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of EPRONTIA 25 MG/ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for EPRONTIA 25 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $2.5545 per ML (NDC 52652900102), effective Aug 19, 2026.

How has the price of EPRONTIA 25 MG/ML SOLUTION changed over time?

Over the history we have for it, the NADAC for EPRONTIA 25 MG/ML SOLUTION has risen 11.4%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for EPRONTIA 25 MG/ML SOLUTION?

Since Apr 17, 2024, the NADAC for EPRONTIA 25 MG/ML SOLUTION has ranged from a low of $2.2854 (Nov 20, 2024) to a high of $2.5545 (Aug 19, 2026), with a median of $2.4801 per ML.

Are there cheaper alternatives to EPRONTIA 25 MG/ML SOLUTION?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPRONTIA 25 MG/ML SOLUTION, is $1.5811 per ML — about 38% below EPRONTIA 25 MG/ML SOLUTION.

Who manufactures EPRONTIA 25 MG/ML SOLUTION?

EPRONTIA 25 MG/ML SOLUTION (NDC 52652900102) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.